Related Experiment Video

Updated: Jul 10, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB

Y Abu-Amer1

  • 1Department of Orthopedic Research and Department of Pathology, Barnes-Jewish Hospital at Washington University School of Medicine, St. Louis, Missouri, USA. abuamery@msnotes.wustl.edu

The Journal of Clinical Investigation
|June 8, 2001
PubMed

Insights

Interleukin-4 (IL-4) inhibits osteoclast differentiation by blocking NF-kappaB activation. This anti-inflammatory effect is mediated through the STAT6 transcription factor, crucial for preventing bone loss.

Area of Science:

  • Immunology
  • Cell Biology
  • Bone Biology

Background:

  • Interleukin-4 (IL-4) is an anti-inflammatory cytokine known to inhibit osteoclast differentiation.
  • Osteoclastogenesis, the formation of bone-resorbing cells, is critically dependent on the activation of Nuclear Factor kappa B (NF-kappaB) signaling pathway.
  • The precise mechanisms by which IL-4 exerts its inhibitory effects on osteoclastogenesis remained largely undefined.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying IL-4's inhibition of osteoclast differentiation.
  • To investigate the role of the Signal Transducer and Activator of Transcription 6 (STAT6) in mediating IL-4's effects on NF-kappaB activation.
  • To determine if STAT6 is essential for IL-4-induced blockade of osteoclastogenesis.

Main Methods:

  • Investigated the effect of IL-4 on NF-kappaB activation, including IkappaB phosphorylation and nuclear translocation.
  • Assessed the impact of STAT6 on NF-kappaB DNA binding activity using electrophoretic mobility shift assays (EMSA).
  • Utilized STAT6 knockout (STAT6-/-) mice to evaluate the necessity of STAT6 in IL-4's anti-osteoclastogenic effects.

Main Results:

  • IL-4 inhibits osteoclast differentiation by suppressing IkappaB phosphorylation, thereby reducing NF-kappaB nuclear translocation and DNA binding activity.
  • STAT6 activation by IL-4 directly antagonizes NF-kappaB transactivation and DNA binding.
  • IL-4 failed to inhibit osteoclastogenesis in STAT6-/- mice, but this effect was restored by exogenous STAT6 addition.

Conclusions:

  • IL-4 effectively blocks osteoclast differentiation through a STAT6-dependent antagonism of NF-kappaB activation.
  • STAT6 is a critical mediator of IL-4's anti-inflammatory actions in the context of bone biology.
  • These findings reveal a novel molecular pathway by which IL-4 regulates bone metabolism.

More Related Videos

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...